about
NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signalingTranscription factor zinc finger and BTB domain 1 is essential for lymphocyte developmentIdentification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein.Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factorsHuman B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphomaThe Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cellsCaspase-activated DNase is required for maintenance of tolerance to lupus nuclear autoantigensTargeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clustersExpression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cellsOsteoimmunology: interactions of the bone and immune systemDistinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5The riddle of the dual expression of IgM and IgDDistinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organsFollicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft RejectionRegulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3Interaction between Mesenchymal Stem Cells and B-CellsZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid MalignanciesThe analysis of clonal expansions in normal and autoimmune B cell repertoiresTargeting the B-cell receptor signaling pathway in B lymphoid malignanciesMicroRNAs in B cell development and malignancyThe pre-B cell receptor; selecting for or against autoreactivityContrasting quiescent G0 phase with mitotic cell cycling in the mouse immune systemEarly B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor SignalingB cells responses and cytokine production are regulated by their immune microenvironmentTargeted disruption of NBS1 reveals its roles in mouse development and DNA repair.B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseasesFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaA point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunityDisruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte developmentTDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivoNormal B-1a cell development requires B cell-intrinsic NFATc1 activityBcl11a is essential for normal lymphoid developmentEssential role of BAX,BAK in B cell homeostasis and prevention of autoimmune diseaseA gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivoMef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasisTranscription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulationPhospholipase Cgamma2 provides survival signals via Bcl2 and A1 in different subpopulations of B cellsIncreased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS, an adaptor molecule containing PH and SH2 domainsImpaired B cell development and function in mice with a targeted disruption of the homeobox gene Hex
P2860
Q24293087-3E81B943-8A4D-4389-9285-BB326550AB66Q24339466-F0786592-934E-402F-85C4-61D0EB0B9789Q24540267-2C0F3761-2EDB-42CE-80A3-991F65F17C80Q24563610-F202BE10-292B-4D91-A69D-C5BD6375CAB1Q24594899-5C9CEBB9-AAAA-47D2-B0A1-E8594CA3E686Q24595213-79880A77-ADB9-46C8-8281-F88110061853Q24621785-AFA68BDD-45DA-4C94-8B71-8EF71BA3AEA2Q24626603-66BC66C3-7CFF-47BA-A3CD-CF4A323AD160Q24645192-0E9B93FD-2F1A-44F6-BF75-9E2D79D434B0Q24646465-9CB715DB-BCD2-4601-9178-F271C72BF9E3Q24655113-66A5CC61-93F0-41DE-B5F7-7347019B1DE1Q24673653-267D3D24-E77B-493A-BC38-14EBCF51B468Q24682937-7DB23D1D-262A-4464-AB11-00A03B8FDE2BQ24801085-0CEAB1E8-9F4A-4989-9EBF-BA3FE6FF42B5Q26738329-F2094040-F4D4-458F-9387-A2898F4E97AEQ26749588-BA910212-B0B9-4E52-89E3-5F32B6B48715Q26750859-4ED3CB63-2080-43AD-985D-875171F83434Q26770729-40FD9B92-6C7E-4AE3-9FBD-92C3DBCD78BAQ26801600-7B4149CA-FEE7-449F-A1CE-1F88B103FF70Q26828782-12733CF3-8469-43DB-9A0E-E541E8837AC3Q26862811-7D6DA2D0-938E-40DC-8C1B-A73BABA60F95Q26864956-D06BE62D-B0F9-4495-BF45-B09FDD8B7C45Q27307703-EB0CFA3B-F6DC-4740-85C5-50EA6E3DE03CQ27487142-1B0D8A1A-415D-4E69-A81B-D744A711C931Q28083170-210916C1-C4A6-4E13-96D0-84F7AF6AC260Q28206244-75CD3564-90BB-471B-A4DB-66ECA2378826Q28208717-63766977-136D-4F60-8637-A000105D7D39Q28282822-1D072F7E-2935-4ECD-BD8A-9A548D8A3587Q28506215-3C05B07C-C642-445E-AC06-4DEA6B9110F4Q28507620-46AC3832-490E-40EF-AAF1-B49600DC6FFAQ28509265-AB9A6198-E4B4-4701-9396-94870F96F438Q28509932-45C1EB91-470C-4F70-8FC9-239A92D0155BQ28511014-252B05FB-5F20-43EF-83AA-0C562528523FQ28513752-1FB661A2-C773-44BE-90B0-7A358D194246Q28539635-44A1726F-AC73-43BE-89E8-F5EE36ECD446Q28585695-96801728-9AB3-4734-BD0D-6BAEE619AC1EQ28586846-2AB7332A-E272-4F54-B2B5-D54654CC2A0AQ28591847-4D1FDE98-05C7-416C-83E8-EE28A797F6B8Q28593801-957E8389-B36F-4C14-A2C8-8D850F0B4B89Q28594302-1F822B88-914B-4D34-955F-D00C05B4AF2D
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
B cell development pathways.
@ast
B cell development pathways.
@en
B cell development pathways.
@nl
type
label
B cell development pathways.
@ast
B cell development pathways.
@en
B cell development pathways.
@nl
prefLabel
B cell development pathways.
@ast
B cell development pathways.
@en
B cell development pathways.
@nl
P1476
B cell development pathways.
@en
P2093
P304
P356
10.1146/ANNUREV.IMMUNOL.19.1.595
P577
2001-01-01T00:00:00Z